Skip to main navigation
Skip to search
Skip to main content
Experts@Minnesota Home
Home
Profiles
Research units
University Assets
Projects and Grants
Research output
Datasets
Press/Media
Activities
Fellowships, Honors, and Prizes
Search by expertise, name or affiliation
Molecular genetic markers in acute myeloid leukemia
Sophia Yohe
Laboratory Medicine and Pathology
Research output
:
Contribution to journal
›
Article
›
peer-review
76
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Molecular genetic markers in acute myeloid leukemia'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Acute Myeloid Leukemia
100%
Molecular Genetic Markers
100%
Risk Stratification
57%
Prognostic Groups
42%
Risk Management
28%
Standard of Care
28%
Gene mutation
28%
Molecular Diagnostics
14%
Clinical Features
14%
Leukemia Patients
14%
Risk Classification
14%
Leukemia Risk
14%
FMS-like Tyrosine Kinase 3 (FLT3)
14%
Leukemia Therapy
14%
Future Risk
14%
CEBPA
14%
Prognosis Prediction
14%
Acute Promyelocytic Leukemia
14%
Genetic Features
14%
Cytogenetic Study
14%
Cytogenetic Assay
14%
Molecular Detection
14%
Molecular mutations
14%
Nucleophosmin 1 (NPM1)
14%
Therapeutic Impact
14%
Prognostic Scoring System
14%
Targeted Testing
14%
Leukemia Classification
14%
Therapy Intensity
14%
Complementary Role
14%
Medicine and Dentistry
Acute Myeloid Leukemia
100%
Genetic Marker
100%
Risk Stratification
57%
Gene Mutation
28%
Acute Promyelocytic Leukemia
14%
Scoring System
14%
NPM1
14%
CCAAT Enhancer Binding Protein Alpha
14%